Accelrys Adds Laboratory Information Management System to Software Suite - - BioPharm International

ADVERTISEMENT

Accelrys Adds Laboratory Information Management System to Software Suite


The Accelrys Process Management and Compliance Suite has been expanded with the addition of the Accelrys Laboratory Information Management System (LIMS), the company announced in a press release. This system uses a process-driven approach, which focuses on laboratory, quality-control, and manufacturing processes, in contrast to the sample-driven approach used by traditional LIMS. This process-driven approach enables organizations to achieve repeatability and consistency of procedures, automatically qualify operational changes, and maintain a lower total cost of ownership.

"Traditional systems deployed to support laboratory operations today lack the flexibility to manage the change inherent in the hand-off between departments that drive the scientific innovation cycle," said IDC Health Insights Research Director Alan Louie, PhD., in the press release. "By coming at LIMS from the process execution standpoint, companies like Accelrys are taking a more holistic approach to managing data. This approach is well suited for lab operations that are trying to drive standardization across changing environments while still maintaining process repeatability and regulatory compliance."

The Accelrys LIMS integrates with Accelrys Electronic Laboratory Notebook (ELN), Accelrys Laboratory Execution System (LES), Accelrys Electronic Batch Records (EBR), Accelrys Discoverant process management informatics, and the Accelrys Enterprise Platform (AEP) for data exchange to provide an end-to-end informatics system that makes data accessible across an organization.

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

EMA Warns of Falsified Herceptin Vials
April 16, 2014
Mallinckrodt to Acquire Questcor Pharmaceuticals
April 16, 2014
American CryoStem and Rutgers University File Joint Patent on Stem Cell Platform
April 11, 2014
Center for Biologics Evaluation and Research Relocates
April 11, 2014
PhRMA Report Reveals Growth Trajectories and Policy Factors Affecting Biopharmaceutical Growth
April 11, 2014
Author Guidelines

Click here